ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CLST Clrstar (DI/S)

48.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Clrstar (DI/S) LSE:CLST London Ordinary Share KYG2294M1050 ORD USD0.0001 (DI / REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 48.50 45.00 52.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

ClearStar,Inc. ClearStar agreement with IntelliCentrics (6788A)

28/03/2017 7:01am

UK Regulatory


Clrstar (DI/S) (LSE:CLST)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Clrstar (DI/S) Charts.

TIDMCLST TIDMCLSU

RNS Number : 6788A

ClearStar,Inc.

28 March 2017

ClearStar's Titer and Drug Screening Solution to be Integrated into IntelliCentrics' SEC(3) URE Program for Hospitals and Healthcare Organisations

ClearStar's automated order placement, registration, automatic transmission, to eliminate the traditional paper-intensive forms and inefficient way of collating data for titer and drug screening tests

ClearStar (AIM: CLSU and CLST), the technology and service provider to the background check industry, is pleased to announce that it has entered into a partnership with IntelliCentrics, the healthcare industry leader with over 10,000 distinct installations of vendor credentialing across the USA, Canada, and the United Kingdom.

Under the terms of the partnership, ClearStar's automated titer and drug screening solution will be integrated into IntelliCentrics' SEC(3)URE Program for Hospitals and Healthcare Organisations. The SEC(3)URE healthcare experience is designed to allow hospitals to control access by healthcare industry representatives (HIR), by ensuring only those that comply with the hospital's specific policies gain access to patient sensitive or restricted areas.

Individual hospitals decide entry requirements, which can include relevant immunisations, professional accreditations and compliance with hospital policies. A titer test measures the existence and levels of antibodies in the blood i.e. the ability to provoke a response from the immune system to disease. This response can come from natural exposure or from vaccination. Rather than hospital staff having to conduct the checks, HIRs pre-register via the SEC(3)URE system, which confirms their compliance status when they arrive on site.

With this partnership, IntelliCentrics has the tools for its members to streamline the titer and drug testing ordering and results, saving time and money. With automated order placement, registration, automatic transmission, it will eliminate the traditional paper-intensive titer and drug test forms, double data-entry, and multiple logins to the test ordering websites.

"Members of the IntelliCentrics community rely on us to deliver and provide the most efficient service and technology to do their jobs at peak levels while concurrently safeguarding a SEC(3) URE healthcare experience for everyone. Our affiliation with ClearStar advances our capability to protect our entire community," comments Mike Sheehan, Global CEO of IntelliCentrics. Sheehan continues "The partnership between IntelliCentrics and ClearStar is at the core of our belief that we all play a role in a safe and SEC(3) URE healthcare experience."

"We are very proud to be working with IntelliCentrics with whom we share a common goal of assuring safety for the healthcare providers and patients through this new best-of-breed solution," stated Robert Vale, CEO of ClearStar. "By integrating our mobile, paperless chain of custody technology with IntelliCentrics' industry-leading service technology infrastructure, we will enable healthcare personnel to be screened and approved for work more quickly thereby meeting the aggressive time demands on the healthcare industry."

Enquiries

 
 ClearStar, Inc. 
 Robert J. Vale, Chief Executive 
  Officer 
  David Pattillo, Chief Financial 
  Officer                            +1 770 416 1900 
 
 finnCap Ltd. 
 Jonny Franklin-Adams, Simon 
  Hicks - Corporate Finance 
  Christian Hobart, Abigail 
  Wayne - Corporate Broking          +44 20 7220 0500 
 
 Luther Pendragon Ltd. 
 Harry Chathli, Claire Norbury       +44 20 7618 9100 
 

Notes to Editors

About ClearStar

ClearStar, Inc. is a leading and trusted background check technology, strategic services, and decision-making information provider to employers and background screening companies.

A seven-time Inc. 5000 honouree and founding member of the National Association of Professional Background Screeners, ClearStar has provided innovative technology solutions to businesses in the human capital management industry from its corporate offices in Alpharetta, Georgia since 1995. For more information about ClearStar, please visit: www.clearstar.net.

About IntelliCentrics

IntelliCentrics, the security experts, is in the business of savings lives by creating a safe and SEC(3)URE healthcare experience. IntelliCentrics is uniquely qualified to help hospitals and healthcare organizations to provide high-quality patient care. By prioritizing security, IntelliCentrics facilities meet or exceed compliance best practices by letting everyone in safely. More healthcare facilities across seven countries adopt IntelliCentrics standards than all competitors combined. Now, every person entering a facility can contribute to preserving patient care, from physicians to patient visitors, vendors, volunteers, and staff. To learn more about IntelliCentrics, the leading provider of managed services to maintain compliance programs to create a safe and SEC(3)URE healthcare experience, please phone (817) SEC(3)URE or visit www.IntelliCentrics.com.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS

The company news service from the London Stock Exchange

END

AGRLLFEAVEIDFID

(END) Dow Jones Newswires

March 28, 2017 02:01 ET (06:01 GMT)

1 Year Clrstar (DI/S) Chart

1 Year Clrstar (DI/S) Chart

1 Month Clrstar (DI/S) Chart

1 Month Clrstar (DI/S) Chart

Your Recent History

Delayed Upgrade Clock